Skip to main content

LataMed AI Corp.

corporate_fare Company Profile

LataMed AI Corp.

LMED·OTC·Technology·CIK 0001477960

Catalyst Crew Technologies Corp. is a development-stage technology company focused on creating and commercializing artificial intelligence-enabled healthcare technology solutions. The company's strategy involves developing an AI healthcare analytics platform and a technology-enabled healthcare services coordination model. These are designed to aid clinical decision-making, patient management, and optimize healthcare delivery by integrating machine learning, data analytics, and software tools for healthcare providers and organizations. Catalyst Crew was incorporated in Nevada on September 11, 2008. Its business focus shifted in February 2026 after acquiring certain healthcare technology assets. As of December 31, 2025, the company had not generated revenue from its current business operations and was still in the development stage. The AI Healthcare Platform is being developed to provide data-driven clinical insights and operational efficiencies. It is intended to use machine learning models, data processing, and analytical tools for areas like disease risk assessment, diagnostic support, and patient monitoring. The technology is designed to be modular and adaptable, integrating with various healthcare data sources, both structured and unstructured. The platform aims to support multiple clinical domains, including cardiovascular, pulmonary, and neurological applications. Current development initiatives include CardioAI, for cardiovascular risk assessment; PulmoAI, for pulmonary condition analysis; and NeuroAI, for neurological condition assessment. These technologies are still under development and have not been commercialized, and the company has not generated revenue from these activities.

LataMed AI Corp. (OTC:LMED) is a publicly traded company in the Technology sector. Wiseek has independently scored 7 items for LMED at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for LMED spans 10-Q.

Recent high-impact activity:

  • LataMed Q3 10-Q: Zero Cash, $198,329 Nine-Month Loss, Going Concern Stands
  • LataMed AI Q2: Going Concern, Zero Cash, and a Super-Voting Preferred Share Shuffle
  • LataMed AI's 5-for-1 Forward Stock Split Expected Next Week, New CUSIP Assigned
  • LataMed AI Executes Alliance with Vértice Seguros, Paving Way for Revenue Generation
  • LataMed AI Explores Partnership with Vertice Seguros to Integrate Healthcare Tech and Insurance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$207.49K
Op. Cash Flow
-$205.79K
Operating Income
-$171.85K
Cash & Equivalents
$0
Debt / Equity
0.00×
Shares Outstanding
44.3M sh
Source: 10-K · filed 2026-05-04 · accession 0001477932-26-002727

Short Interest & Short Volume

On November 20, 2026, 40.1% of LMED volume reported to FINRA trade-reporting facilities was marked short.

Daily short volume (FINRA facilities)40.1% of 46,155 shares on November 20, 2026
5-day average short volume27.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with L →
$0.032 -8.26% today
52-week range · as of 2026-11-13 $0.0261 – $135
Market cap
$5.78M
Volume
46.2K (1.2× avg)
3-mo avg 39.4K
Live data · 2026-11-22 11:30 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LMED - Latest Insights

LMED
Nov 13, 2026, 1:42 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0365
Real-time Price: $0.032 info
Change: -$0.0045 (-12%) info
Market Cap: $5.782M info
LMED
Aug 11, 2026, 3:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.660
Real-time Price: $0.032 info
Change: -$0.628 (-95%) info
Market Cap: $5.782M info
LMED
Jul 08, 2026, 7:05 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $3.85
Real-time Price: $0.032 info
Change: Stock Split info
Market Cap: $5.782M info
LMED
Jun 30, 2026, 8:53 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $3.55
Real-time Price: $0.032 info
Change: Stock Split info
Market Cap: $5.782M info
LMED
Jun 15, 2026, 9:05 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $2.44
Real-time Price: $0.032 info
Change: Stock Split info
Market Cap: $5.782M info
LMED
May 20, 2026, 2:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.73
Real-time Price: $0.032 info
Change: Stock Split info
Market Cap: $5.782M info
LMED
May 14, 2026, 9:36 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $2.53
Real-time Price: $0.032 info
Change: Stock Split info
Market Cap: $5.782M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets